| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.32B | 54.38B | 55.05B | 68.26B | 62.28B | 44.34B |
| Gross Profit | 17.56B | 17.12B | 18.00B | 24.48B | 19.34B | 11.65B |
| EBITDA | 5.09B | 4.83B | 6.49B | 12.88B | 9.78B | 3.27B |
| Net Income | 1.65B | 978.00M | 2.67B | 7.47B | 4.13B | 215.00M |
Balance Sheet | ||||||
| Total Assets | 120.52B | 120.67B | 119.19B | 114.35B | 107.08B | 100.95B |
| Cash, Cash Equivalents and Short-Term Investments | 24.17B | 24.43B | 19.77B | 18.85B | 18.00B | 15.49B |
| Total Debt | 31.96B | 34.90B | 32.71B | 22.12B | 23.86B | 29.22B |
| Total Liabilities | 44.20B | 45.03B | 43.02B | 42.68B | 43.10B | 41.52B |
| Stockholders Equity | 76.32B | 75.63B | 76.16B | 71.66B | 63.97B | 59.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.27B | -6.79B | 4.21B | 8.47B | 2.71B |
| Operating Cash Flow | 0.00 | 6.45B | -2.49B | 6.40B | 10.27B | 5.66B |
| Investing Cash Flow | 0.00 | -3.44B | -5.30B | -2.70B | -2.10B | -3.01B |
| Financing Cash Flow | 0.00 | 912.00M | 7.57B | -3.35B | -6.44B | -412.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥790.00B | 18.30 | 9.10% | 1.63% | 6.28% | 2.62% | |
74 Outperform | ¥90.68B | 7.58 | ― | 3.85% | 9.38% | 8.88% | |
72 Outperform | ¥250.38B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
67 Neutral | ¥72.16B | 11.27 | ― | 2.82% | 8.75% | 177.16% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥112.14B | 26.06 | 2.64% | 2.30% | -4.11% | 46.76% | |
52 Neutral | ¥206.29B | 85.52 | -4.83% | 3.08% | -3.18% | -531.48% |